MYCN and triple-negative breast carcinoma: Given Mycn’s oncogenic potential in various cancers, including triple-negative breast cancer, our research further suggests that Mycn not only plays a core regulatory role in mammary development, but that its expression imbalance may also be an important driving factor in cancer occurrence.